High-definition Transcranial Direct Current Stimulation (HD-tDCS) Verbal Learning
This study is currently recruiting participants.
Verified November 2012 by The University of New South Wales
Sponsor:
The University of New South Wales
Information provided by:
The University of New South Wales
ClinicalTrials.gov Identifier:
NCT01733576
First received: November 26, 2012
Last updated: June 14, 2013
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This project will use a new form of non-invasive brain stimulation called high-definition transcranial direct current stimulation (HD-tDCS) to facilitate verbal learning. This form of stimulation is similar to transcranial direct current stimulation (tDCS) but allows for more spatially focused stimulation. We hypothesise that HD-tDCS when applied to regions of the brain important for learning and memory will improve verbal learning and memory compared to sham HD-tDCS.
| Condition | Intervention | Phase |
|---|---|---|
|
Verbal Learning and Memory |
Device: HD-tDCS |
Phase 0 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Single Blind (Subject) Primary Purpose: Basic Science |
| Official Title: | Enhancing Verbal Learning and Memory Using High-Definition Transcranial Direct Current Stimulation (HD-tDCS) |
Resource links provided by NLM:
Further study details as provided by The University of New South Wales:
Primary Outcome Measures:
- Ray Auditory Verbal Learning Test (RAVLT) [ Designated as safety issue: No ]
| Estimated Enrollment: | 16 |
| Estimated Primary Completion Date: | March 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Sham Comparator: Sham HD-tDCS | Device: HD-tDCS |
| Active Comparator: Active HD-tDCS 1 | Device: HD-tDCS |
| Active Comparator: Active HD-tDCS 2 | Device: HD-tDCS |
| Active Comparator: Active HD-tDCS 3 | Device: HD-tDCS |
Eligibility| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Ages 18 - 40 years
- Right-handed
Exclusion Criteria:
- concurrent medication likely to affect mental performance
- current history of drug or alcohol abuse or dependence
- any psychiatric or neurological disorder, recent head injury, or history of seizure or stroke.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01733576
Contacts
| Contact: Donel Martin, PhD | 61 2 9382 9261 | donel.martin@unsw.edu.au |
Locations
| Australia, New South Wales | |
| Black Dog Institute | Recruiting |
| Sydney, New South Wales, Australia, 2031 | |
| Contact: Donel Martin, PhD 61 2 9382 9261 donel.martin@unsw.edu.au | |
| Principal Investigator: Donel Martin, PhD | |
Sponsors and Collaborators
The University of New South Wales
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT01733576 History of Changes |
| Other Study ID Numbers: | CB64 |
| Study First Received: | November 26, 2012 |
| Last Updated: | June 14, 2013 |
| Health Authority: | Australia: Therapeutic Goods Administration |
ClinicalTrials.gov processed this record on June 17, 2013